Rosuvastatin (marketed by AstraZeneca as Crestor Abbott Laboratories as R2) is a member of the drug class of statins used in combination with exercise diet and weight-loss to treat high cholesterol and related conditions and to prevent cardiovascular disease. It was developed by Shionogi. Crestor is the fifth-highest selling drug in the United States accounting for approx. $2.6 billion in sales in 2013.
This page contains content from the copyrighted Wikipedia article "Rosuvastatin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
